Exhibit 10.1

Asset Purchase Agreement
By and Among
USA Equities Trust, Inc., as Buyer
and
Green US Builders, Inc., as Seller

Real Property at 1191-1209 East Main Street
Bridgeport, CT, Fairfield County, CT

July 31, 2015

ASSET PURCHASE AGREEMENT

THIS ASSET PURCHASE AGREEMENT (the "Agreement"), dated as of the 31st day of
July, 2015, by and between USA Equities Trust, Inc., a Delaware corporation and
a wholly-owned subsidiary of American Biogenetic Sciences, Inc., a Delaware
corporation and a public company with its principal place of business at 79 East
Putnam Avenue, Greenwich CT 06830 (the "Buyer") and Green US Builders, Inc., a
Delaware corporation with its principal place of business at 281 Riversville
Road, Greenwich CT 06831 (the "Seller"). The Buyer and the Seller are sometimes
referred to herein individually, as the "Party" and collectively, as the
"Parties."

WHEREAS, the Seller owns a parcel of commercial real estate located at 1191-1209
East Main Street, Bridgeport, CT (the "Seller's Asset") as more fully described
in Article 1 and Exhibit 1 below; and

WHEREAS, the Buyer wishes to purchase and the Seller desires to sell, transfer
and assign the Seller's Asset for the consideration set forth in Article 2
below.

NOW, THEREFORE, in consideration of the foregoing premises and the mutual
representations, warranties, covenants, and agreements contained herein, the
adequacy and legal sufficiency of which are hereby acknowledged, the Parties
hereby agree as follows:

ARTICLE 1

ASSET PURCHASE

1.1 Seller's Asset.
The Seller's Asset consists of that parcel of commercial property located at
1191-1209 East Main Street, Bridgeport, Fairfield County, State of Connecticut
as more fully described in Exhibit 1 hereto;
(a) The Seller acknowledge and agree that it shall sell, transfer and assign all
right, title and interest in Seller's Asset free and clear of all liens, claims
and encumbrances, as defined below (collectively, the "Encumbrances");

ARTICLE 2

CONSIDERATION FOR THE ASSETS; THE CLOSING

2.1 Consideration.
(a) The consideration payable and to be delivered to the Seller or Seller's
designees for the sale, transfer and assignment to Buyer of Seller's Asset (the
"Share Consideration) representing two million four hundred thousand (2,400,000)
restricted shares of common stock, par value $0.0001 (the "Shares"), of American
Biogenetic Sciences, Inc.
(b) The Share Consideration shall be evidenced by certificate(s) issued in the
name of the Seller or Seller's designee(s), which certificate(s) shall bear a
restrictive legend reflecting that the Shares have not been registered under the
Securities Act of 1933, as amended (the "Act") as mandated by the Securities and
Exchange Commission (the "SEC") and as required by Buyer's transfer agent,
Continental Stock Transfer & Trust Co. (the "Transfer Agent").

2.2 The Closing.
(a) At the closing, which shall occur on or before August 7, 2015 (the
"Closing"), the Seller shall deliver such instruments, deeds and other
documentation evidencing the delivery to Buyer of all right, title and interest
in Seller's Asset, free of all Encumbrances, as defined below.
(b) Simultaneous with the Closing, the Buyer shall give written instructions to
the Transfer Agent authorizing the delivery the Share Consideration, as set
forth in Section 2.1 above.

ARTICLE 3

SELLER' REPRESENTATIONS AND WARRANTIES

The Seller hereby represents and Warrants to Buyer as follows:
3.1 Organization, etc. Seller is a corporation duly organized, validly existing
and in good
standing under the laws of the State of Delaware. The Seller has all requisite
power to own, lease and operate all of its respective assets owned by it in
connection with the conduct of its business, as well as to sell, transfer and
assign Seller's Asset subject to this Agreement and to carry on the operations
of the business of Seller as now being conducted.
3.2 Good Standing. The Seller is duly qualified or licensed to do business and
is in good
standing in the State of Connecticut, the jurisdiction in which the Seller's
Asset that is being sold by it pursuant to this Agreement.
3.3 Authorization. The Seller has all requisite power and authority to enter
into, execute, deliver, and perform its obligations under this Agreement and
those other agreements and instruments required to be executed or delivered
under this Agreement, and to perform its obligations hereunder. This Agreement
has been duly and validly executed and delivered by the Seller and is the valid
and binding legal obligation of the Seller enforceable against the Seller in
accordance with its terms, subject to bankruptcy, moratorium, principles of
equity and other limitations limiting the rights of creditors generally. Upon
the execution and delivery of this Agreement by Buyer, and any other agreements
to be executed and delivered by Buyer pursuant hereto, when fully executed and
delivered, will constitute, a valid and binding obligation of the Seller
enforceable against it in accordance with their terms, except to the extent that
enforcement thereof may be subject to applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance and similar laws now or
hereafter affecting creditors' rights generally and general principles of equity
(regardless of whether enforceability is considered in a proceeding at law or in
equity).
3.4 No Conflict, etc. Neither the execution and delivery by the Seller of this
Agreement nor the performance by the Seller of its obligations hereunder will
(i) conflict with or result in any breach of any provision of the charter
documents or bylaws of any Seller; (ii) result in (with or without the giving of
notice or lapse of time or both) a material violation or breach of, or
constitute a default or give rise to any right of termination, cancellation or
acceleration under any of the terms, conditions or provisions of any
indebtedness, license, lease or contract or similar instrument or obligation to
which any Seller, or by which any of the Asset, may be bound; or (iii) violate
any order, injunction, decree, statute, rule or regulation of any jurisdiction,
whether local or foreign governmental entity or subdivision thereof or court,
tribunal, commission, board, bureau, agency or legislative, executive,
governmental or regulatory authority or agency to which any Seller or its
business is subject.
3.5 Good Title. the Seller owns the Seller's Asset and has and will deliver to
Buyer, good,
valid and marketable title to, the Seller's Asset, free and clear of all
mortgages, pledges, security interests, liens (including tax liens), charges,
options or other encumbrances of any nature whatsoever (collectively, the
"Encumbrances"). Exhibit 1.1 contains a complete and accurate legal description
of the Seller's Asset.
3.6 Consents and Approvals. No consent, approval, order or authorization of or
from, or
registration, notification, declaration or filing with any individual or entity
is required in connection with the performance of this Agreement by the Seller
or the consummation by the Seller and Buyer of the transactions contemplated
herein.
3.7 Absence of Undisclosed Liabilities. The Seller represents that it does not
have any
liabilities, obligations or claims of any kind whatsoever ("Liabilities") that
encumber, or in the future may encumber, the Seller's Asset.
3.8 Litigation. There is no legal, administrative, arbitration, or other
proceeding, suit, claim or action of any nature or investigation, review or
audit of any kind, or any judgment, decree, decision, injunction, writ or order
pending, noticed, scheduled, or, to the knowledge of Seller, threatened or
contemplated by or against or involving the Company.
3.9 No Broker or Finder. The Seller has not employed any broker, finder,
investment
banker or financial advisor or incurred any liability for any brokerage fee or
commission, finder's fee or financial advisory fee, in connection with the
transactions contemplated hereby, nor is there any basis known to Seller for any
such fee or commission to be claimed by any person or entity.
3.10 Compliance with Law; Permits and Other Operating Rights. The Seller is and
has been in compliance in all respects with all laws applicable to its business
and the operation of Seller's Asset.

ARTICLE 4

BUYER'S REPRESENTATIONS AND WARRANTIES

Buyer hereby represents and Warrants to the Seller as follows:
4.1 Authorization and Power. Buyer has all power and authority to enter into
this
Agreement and to carry out the transactions contemplated herein. This Agreement
is the valid and binding legal obligation of Buyer enforceable against Buyer in
accordance with its terms, except as such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization or similar laws that affect
creditors' rights generally.
4.2 Good Standing. The Buyer and its parent, American Biogenetic Sciences, Inc.
is a
corporation duly organized, validly existing and in good standing under the laws
of the State of Delaware with the requisite corporate power and authority to
carry on its business as it is now being conducted and to own, operate and lease
its properties and assets.
4.3 Authorization. Buyer has all requisite power and authority to enter into,
execute,
deliver, and perform its obligations under this Agreement and those other
agreements and instruments required to be executed or delivered under this
Agreement, and to perform its obligations hereunder. This Agreement has been
duly and validly executed and delivered by Buyer and is the valid and binding
legal obligation of Buyer enforceable against Buyer in accordance with its
terms, subject to bankruptcy, moratorium, principles of equity and other
limitations limiting the rights of creditors generally. Upon the execution and
delivery of this Agreement, and any other agreements to be executed and
delivered pursuant hereto, when fully executed and delivered, will constitute, a
valid and binding obligation of Buyer enforceable against it in accordance with
their terms, except to the extent that enforcement thereof may be subject to
applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance and similar laws now or hereafter affecting creditors' rights
generally and general principles of equity (regardless of whether enforceability
is considered in a proceeding at law or in equity).
4.4 No Conflict, etc. Neither the execution and delivery by Buyer of this
Agreement nor the performance by Buyer of its obligations hereunder will (i)
conflict with or result in any breach of any provision of the charter documents
or bylaws of Buyer; (ii) result in (with or without the giving of notice or
lapse of time or both) a material violation or breach of, or constitute a
default or give rise to any right of termination, cancellation or acceleration
under any of the terms, conditions or provisions of any indebtedness, license,
lease or contract or similar instrument or obligation to which Buyer, or by
which any of the Asset, may be bound, whether local or foreign governmental
entity or subdivision thereof or court, tribunal, commission, board, bureau,
agency or legislative, executive, governmental or regulatory authority or agency
to which Buyer or its business is subject.
4.5 Non-Contravention. Neither the execution, delivery nor performance of this
Agreement
and each other transaction document nor the consummation of the transactions
contemplated hereby or thereby will:
(a) be in conflict with, or constitute a default, however defined (or an event
which,
with the giving of due notice or lapse of time, or both, would constitute such a
default), under any agreement to which Buyer is a party; or
(b) violate any law.
4.6 Consents and Approvals. No consent is required by any person or entity in
connection
with the execution, delivery and performance by Buyer of its obligation under
the Agreement or the consummation of the transactions contemplated herein.
4.7 Litigation. There is no legal, administrative, arbitration, or other
proceeding, suit, claim
or action of any nature or investigation, review or audit of any kind, or any
judgment, decree, decision, injunction, writ or order pending, noticed,
scheduled, or, to the knowledge of Buyer, threatened or contemplated by or
against or involving Buyer or its business, or which questions or challenges the
validity of this Agreement or any action taken or to be taken by the Parties
hereto pursuant to the transactions contemplated herein.
4.8 No Broker or Finder. No broker, finder or investment banker is entitled to
any
brokerage, finder's or other fee or commission payable by Buyer in connection
with the this Agreement or the transaction contemplated herein, based upon
arrangements made by or on behalf of Buyer.

ARTICLE 5

CONDITIONS TO THE OBLIGATIONS OF BUYER

Notwithstanding any other provision of this Agreement to the contrary, the
obligation of Buyer to effect the transactions contemplated herein will be
subject to the satisfaction at or prior to the Closing, or waiver by Buyer, of
each of the following conditions:
5.1 Representations and Warranties True. The representations and warranties of
the
Seller contained in this Agreement will be true, complete and accurate in all
material respects as of the date when this Agreement shall be executed, which
shall also be the date of Closing.
5.2 Performance. The Seller will have performed and complied in all material
respects with all agreements, covenants, obligations and conditions required by
this Agreement to be performed or complied with by the Seller on the Closing.
5.3 Required Approvals and Consents.
(a) All action required by law to authorize the execution, delivery and
performance of this Agreement and the consummation of the transactions
contemplated hereby will have been duly and validly taken.
(b) All consents of or from all authorities required hereunder to consummate the
transactions contemplated herein, if necessary, will have been delivered, made
or obtained, and Buyer will have received copies thereof.
5.4 Adverse Changes. No material adverse change will have occurred in the
business, financial condition or operations of the Seller that may have any
Adverse Change on the Seller's Asset.
5.5 No Proceeding or Litigation. No suit, action, investigation, inquiry or
other proceeding
by any authority or other person or entity will have been instituted or
threatened which delays or questions the validity or legality of the
transactions contemplated hereby or which, if successfully asserted, would, in
the reasonable judgment of Buyer, individually or in the aggregate, otherwise
have a material adverse effect on the Seller's Asset or operations or prevent or
delay the consummation of the transactions contemplated by this Agreement.

ARTICLE 6

CONDITIONS TO OBLIGATIONS OF SELLER

Notwithstanding any other provision of this Agreement to the contrary, the
obligation of the Seller to effect the transactions contemplated herein will be
subject to the satisfaction at or prior to the Closing, or waiver by the Seller,
of each of the following conditions:
6.1 Representations and Warranties True. The representations and warranties of
Buyer
contained in this Agreement will be true, complete and accurate in all material
respects as of the date when this Agreement shall be executed, which shall also
be the date of Closing.
6.2 Performance. Buyer will have performed and complied in all material respects
with all
agreements, covenants, obligations and conditions required by this Agreement to
be performed or complied with by Buyer on the Closing.
6.3 Required Approvals and Consents.
(a) All action required by law to authorize the execution, delivery and
performance of
this Agreement and the consummation of the transactions contemplated hereby will
have been duly and validly taken.
(b) All consents of or from all authorities required hereunder to consummate the
transactions contemplated herein, if necessary, will have been delivered, made
or obtained, and Buyer will have received copies thereof.
6.4 Adverse Changes. No material adverse change will have occurred in the
business or
financial condition of Buyer that may have any Adverse Change on Buyer.
6.5 No Proceeding or Litigation. No suit, action, investigation, inquiry or
other proceeding
by any authority or other person or entity will have been instituted or
threatened which delays or questions the validity or legality of the
transactions contemplated hereby or which, if successfully asserted, would, in
the reasonable judgment of the Seller, individually or in the aggregate,
otherwise have a material adverse effect on Buyer's financial condition or
operations or prevent or delay the consummation of the transactions contemplated
by this Agreement.

ARTICLE 7

INDEMNIFICATION

7.1 Survival of Representations and Warranties. The representations and
warranties of the Parties contained herein or in any signed writing delivered in
connection with this Agreement will survive for a period of one (1) year after
the execution of this Agreement.
7.2 Seller's Indemnification. The Seller will indemnify Buyer and its officers,
directors, agents and representatives, in their capacities as such, and the
successors, heirs and personal representatives of any of them (collectively, the
"Buyer Indemnified Parties") against and hold them harmless from any and all
damage, loss, liability and expense (including, without limitation, reasonable
expenses of investigation and attorneys' fees and expenses) (collectively
"Loss") incurred or suffered by any Buyer Indemnified Party arising out of or
relating to any breach of any representation, warranty, covenant or other
agreement of the Seller contained herein.
7.3 Buyer's Indemnification. Buyer will indemnify the Seller and its officers,
directors,
agents and representatives, in their capacities as such, and the successors,
heirs and personal representatives of any of them (collectively, the "Seller
Indemnified Parties") against and hold them harmless from any and all Loss
incurred or suffered by any Seller Indemnified Party arising out of or relating
to any breach of any representation, warranty, covenant or other agreement of
Buyer contained herein.
7.4 Persons Seeking Indemnification. Any person seeking indemnification pursuant
to Article 7, Sections 7.2 and 7.3 above (an "Indemnified Party") with respect
to a claim, action or proceeding by any person who is not a Buyer Indemnified
Party or a Seller Indemnified Party will give prompt written notice to the Party
from whom such indemnification is sought (the "Indemnifying Party") of the
assertion of any claim, or the commencement of any action or proceeding, in
respect of which indemnity may be sought hereunder; provided that the failure to
give such notice will not affect the Indemnified Party's rights to
indemnification hereunder, unless such failure would prejudice in any material
respect the Indemnifying Party's ability to defend such claim, action or
proceeding. The Indemnifying Party will have the right to assume the defense of
any such action or proceeding at its expense, provided that in the reasonable
judgment of the Indemnified Party, the Indemnifying Party has adequate resources
to undertake such defense and satisfy any indemnifiable Loss arising from such
action or proceeding and the selection of counsel is approved by the Indemnified
Party (which approval will not be unreasonably withheld or delayed). If the
Indemnified Party so determines that the Indemnifying Party does not have
adequate resources, or the Indemnifying Party does not elect to assume the
defense of any such action or proceeding, or fails to make such an election
within twenty (20 days after it receives such notice pursuant to the first
sentence of this Section 7.4, the Indemnified Party may assume such defense at
the expense of the Indemnifying Party. The Indemnified Party will have the right
to participate in (but not control) the defense of an action or proceeding
defended by the Indemnifying Party hereunder and to retain its own counsel in
connection with such action or proceeding, but the fees and expenses of such
counsel will be at the Indemnified Party's expense unless (i) the Indemnifying
Party and the Indemnified Party have mutually agreed in writing to the retention
of such counsel or (ii) the named parties in any such action or proceeding
(including impleaded parties) include the Indemnifying Party and the Indemnified
Party, and representation of the Indemnifying Party and the Indemnified Party by
the same counsel would create a conflict, provided that, unless otherwise agreed
by the Indemnifying Party, if the Indemnifying Party is obligated to pay the
fees and expenses of such counsel, the Indemnifying Party will be obligated to
pay only the fees and expenses associated with one attorney or law firm, as
applicable, for the Indemnified Party. An Indemnifying Party will not be liable
under Sections 7.2 or 7.3 for any settlement effected without its written
consent, which consent will not be unreasonably withheld or delayed, of any
claim, action or proceeding in respect of which indemnity may be sought
hereunder.

ARTICLE 8

MISCELLANEOUS PROVISIONS

8.1 Expenses. Buyer and the Seller will each bear their own costs and expenses
relating
to the transactions contemplated hereby, including without limitation, fees and
expenses of legal counsel, accountants, finders, consultants or other
representatives for the services used, hired or connected with the transactions
contemplated hereby. Neither Buyer nor any Seller will charge any of his
expenses to any other Party or seek reimbursement from any Party for any of its
expenses.
8.2 Amendment and Modification. Subject to applicable law, this Agreement may be
amended or modified by the Parties at any time with respect to any of the terms
contained herein; provided, however, that all such amendments and modifications
must be in writing duly executed by all of the Parties hereto.
8.3 Waiver of Compliance; Consents. Any failure of a Party to comply with any
obligation, covenant, agreement or condition herein may be expressly waived in
writing by the Party entitled hereby to such compliance, but such waiver or
failure to insist upon strict compliance with such obligation, covenant,
agreement or condition will not operate as a waiver of, or estoppel with respect
to, any subsequent or other failure. No single or partial exercise of a right or
remedy will preclude any other or further exercise thereof or of any other right
or remedy hereunder. Whenever this Agreement requires or permits the consent by
or on behalf of a Party, such consent will be given in writing in the same
manner as for waivers of compliance.
8.4 No Third Party Beneficiaries. Nothing in this Agreement will entitle any
person or entity (other than a Party hereto and his respective successors and
assigns permitted hereby) to any claim, cause of action, remedy or right of any
kind.
8.5 Notices. All notices, requests, demands and other communications required or
permitted hereunder will be made in writing and will be deemed to have been duly
given and effective: (i) on the date of delivery, if delivered personally; (ii)
on the earlier of the fourth (4th) day after mailing or the date of the return
receipt acknowledgement, if mailed, postage prepaid, by certified or registered
mail, return receipt requested; or (iii) on the date of transmission, if sent by
facsimile, telecopy, telegraph, telex or other similar telegraphic
communications equipment, or to such other person or address as the Parties
hereto in writing in accordance with this subsection, as follows:

If to Buyer, then to:
USA Equities Trust, Inc.
Attn: Troy Grogan, President
c/o American Biogenetic Sciences, Inc.
79 East Putnam Avenue
Greenwich CT 06830

If to Seller, then to:
Green US Builders, Inc.,
281 Riversville Road
Greenwich CT 06831
Attn: Joseph Gaga, President or to such other persons or addresses as Buyer and
Seller will furnish to the other in writing in accordance with this Agreement.

8.6 Assignment. This Agreement and all of the provisions hereof will be binding
upon and inure to the benefit of the Parties and their respective successors and
permitted assigns, but neither this Agreement nor any of the rights, interests
or obligations hereunder will be assigned (whether voluntarily, involuntarily,
by operation of law or otherwise) by any Seller without the prior written
consent of Buyer.
8.7 Governing Law. This Agreement will be governed by and construed in
accordance with the laws of the State of Connecticut without regard to its
conflict of law rules, principles or provisions of such state or of any other
state. The sole jurisdiction and venue for any litigation arising out of this
Agreement will be an appropriate federal or district court located in the State
of Connecticut, and each Party hereby consents to such jurisdiction. The Party
agrees not to raise and waives any objection to or defense based on the venue of
any such court or forum non conveniens.
8.8 Counterparts. This Agreement may be executed simultaneously in one or more
counterparts, each of which will be deemed an original, but all of which
together will constitute one and the same instrument.
8.9 Facsimile and Scanned Execution. Receipt by either Party of a counterpart of
this
Agreement manually signed and then scanned electronically and E-mailed to the
other Party or manually signed and then sent by facsimile transmission to the
other Party shall, for all purposes, be deemed to be an original counterpart
with the same force and effect as the manually signed counterpart from which it
was electronically reproduced.
8.10 Headings. The headings of the sections and subsections of this Agreement
are
inserted for convenience only and will not constitute a part hereof.
8.11 Entire Agreement. This Agreement and the exhibits and other writings
referred to in
this Agreement or in any such exhibit or other writing are part of this
Agreement, together they embody the entire agreement and understanding of the
Parties hereto in respect of the transactions contemplated by this Agreement and
together they are referred to as this Agreement or the transactions contemplated
hereby. There are no restrictions, promises, warranties, agreements, covenants
or undertakings, other than those expressly set forth or referred to in this
Agreement. This Agreement supersedes all prior agreements and understandings
between the Parties with respect to the transaction or transactions contemplated
by this Agreement. Provisions of this Agreement will be interpreted to be valid
and enforceable under applicable Law to the extent that such interpretation does
not materially alter this Agreement; provided, however, that if any such
provision becomes invalid or unenforceable under applicable Law such provision
will be stricken to the extent necessary and the remainder of such provisions
and the remainder of this Agreement will continue in full force and effect.

(Signatures on Following Page)

USA Equities Trust, Inc. as Buyer
and American Biogenetic Sciences, Inc.,
By: Troy Grogan, as Authorized Signatory and Principal Shareholder,
Respectively
Date: July 31, 2015
and
Green US Builders, Inc., as Seller

Date: July 31, 2015

EXHIBIT 1

The subject parcel of real property is located at 1191-1209 East Main Street on
the northerly side of the SW corner of Shelton Street and on the westerly side
of East Main Street in the City of Bridgeport, County of Fairfield, State of
Connecticut (the "Property"). The Property consists of a 2 and 2.5 story,
mix-use building (mix-use meaning commercial and residential), with 5
retail/commercial spaces on the ground floor and 5 apartments on the upper
floors. The Property is recorded in Bridgeport Land Records maintained at
Bridgeport Assessor's Office as Lot 10, Block 1735 on Map 48.